HAC (Russian)
RSCI (Russian)
EBSCO
DOI (USA)
Ulrichsweb (Ulrich’s Periodicals Directory)
Scientific Indexing Services

Current possibilities for assessing and predicting the severity of community-acquired pneumonia

DOI: https://doi.org/10.29296/25877305-2022-07-03
Issue: 
7
Year: 
2022

Yu. Rubtsov, Candidate of Medical Sciences; Yu. Goverdovsky, MD; A. Mikhailov; G. Tsepkova, Candidate of Medical Sciences
S.M. Kirov Military Medical Academy, Ministry of Defense of Russia; Saint Petersburg

Late admission to the intensive care unit is associated with increased mortality in severe community-acquired pneumonia (CAP). The purpose of the study was to summarize current data on the possibilities of assessing and predicting the severity of CAP. The effectiveness of predicting the severity of CAP was evaluated using the most popular scales. The current procedures for assessment and prediction are focused on the early detection of respiratory and cardiovascular insufficiency and other types of internal organ dysfunctions. The inclusion of various biomarkers substantially increases the informative values of the scales. However, none of the scales can be an absolutely accurate tool and they should be considered as an additional aid in clinical practice.

Keywords: 
pulmonology
community-acquired pneumonia
severity prediction
assessment scales
biomarkers



References: 
  1. Zaitsev A.A. Community-acquired Pneumonia: Diagnostic, Treatment and Vaccine Prevention Opportunities in the Context of the COVID-19 Pandemic. Prakticheskaya pul’monologiya. 2020; 1: 14–20 (in Russ.).
  2. Chuchalin A.G., Sinopal’nikov A.I., Kozlov R.S. et al. Klinicheskie rekomendatsii po diagnostike, lecheniiu i profilaktike tiazheloi vnebol’nichnoi pnevmonii u vzroslykh. M., 2014 (in Russ.).
  3. Chalmers J.D., Singanayagam A., Akram A.R. et al. Severity assessment tools for predicting mortality in hospitalised patients with community-acquired pneumonia. Thorax. 2010; 65 (10): 878–83. DOI: 10.1136/thx.2009.133280
  4. Chalmers J.D., Taylor J.K., Mandal P.et al. Validation of the Infectious Diseases Society of America/American Thoratic Society minor criteria for intensive care unit admission in community-acquired pneumonia patients without major criteria or contraindications to intensive care unit care. Clin Infect Dis. 2011; 53 (6): 503–11. DOI: 10.1093/cid/cir463
  5. Chalmers J.D., Mandal P., Singanayagam A. et al. Severity assessment tools to guide ICU admission in community-acquired pneumonia: systematic review and meta-analysis. Intensive Care Med. 2011; 37 (9): 1409–20. DOI: 10.1007/s00134-011-2261-x
  6. Marti C., Garin N., Grosgurin O. et al. Prediction of severe community-acquired pneumonia: a systematic review and meta-analysis. Crit Care. 2012; 27 (16): 141. DOI: 10.1186/cc11447
  7. Fine M.J., Auble T.E., Yealy D.M. et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med. 1997; 336 (4): 243–50. DOI: 10.1056/NEJM199701233360402
  8. Lim W.S., Baudouin S.V., George R.C. et al. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax. 2009; 64 (Suppl 3): 1–55. DOI: 10.1136/thx.2009.121434
  9. Brown S.M., Jones B.E., Jephson A.R. et al. Validation of the Infectious Disease Society of America/American Thoracic Society 2007 guidelines for severe community-acquired pneumonia. Crit Care Med. 2009; 37 (12): 3010–6. DOI: 10.1097/CCM.0b013e3181b030d9
  10. Charles P.G., Wolfe R., Whitby M. et al. SMART-COP: a tool for predicting the need for intensive respiratory or vasopressor support in community-acquired pneumonia. Clin Infect Dis. 2008; 47 (3): 375–84. DOI: 10.1086/589754
  11. Espana P.P., Capelastegui A., Gorordo I. et al. Development and validation of a clinical prediction rule for severe community-acquired pneumonia. Am J Respir Crit Care Med. 2006; 174 (11): 1249–56. DOI: 10.1164/rccm.200602-177OC
  12. Zaytsev A.A., Ovchinnikov Yu.V., Kondrat’eva T.V. An analysis of diagnostic values of prognostic tools for communityacquired pneumonia in young patients in a closed community. Pulmonologiya. 2014; 5: 67–72 (in Russ.). DOI: 10.18093/0869-0189-2014-0-5-67-72
  13. Khalimov Yu.Sh., Rubtsov Yu.E., Gusev R.V. et al. Community-acquired pneumonia in young adults: diagnostic significance of different criteria of severe. Modern problems of science and education. 2014; 6: 1187–92 (in Russ.).
  14. Rubtsov Yu.E., Khalimov Yu.Sh., Gayduk S.V. et al. New possibilities for assessing the severity of community-acquired pneumonia among military personnel. Vestnik Rossiyskoy Voenno-meditsinskoy akademii. 2019; 1 (65): 50–5 (in Russ.).
  15. Ovchinnikov Y.V., Zaitsev A.A., Sinopalnikov A.I. et al. Community-acquired pneumonia in servicemen: patients suirvalence and antimicrobial therapy. Russian Military Medical Journal. 2016; 337 (3): 4–14 (in Russ.). DOI: 10.17816/RMMJ73539
  16. Jiang J., Yang J., Jin Y. et al. Role of qSOFA in predicting mortality of pneumonia: A systematic review and meta-analysis. Medicine (Baltimore). 2018; 97 (40): 12634. DOI: 10.1097/MD.0000000000012634
  17. Middleton D.J., Smith T.O., Bedford R. et al. Shock Index Predicts Outcome in Patients with Suspected Sepsis or Community-Acquired Pneumonia: A Systematic Review. J Clin Med. 2019; 8 (8): 1144. DOI: 10.3390/jcm8081144
  18. Sungurlu S., Balk R.A. The Role of Biomarkers in the Diagnosis and Management of Pneumonia. Clin Chest Med. 2018; 39 (4): 691–701. DOI: 10.1016/j.ccm.2018.07.004
  19. Mira J.P., Max A., Burgel P.R. The role of biomarkers in community-acquired pneumonia: predicting mortality and response to adjunctive therapy. Crit Care. 2008; 12 (6): 1–7.
  20. Khalimov Yu.Sh., Rubtsov Yu.E., Yazenok A.V. et al. The state of the thyroid status in patients with severe community-acquired pneumonia. Fundamental Research. 2014; 10 (8): 1587–90 (in Russ.).
  21. Pereira J.M., Laszczyńska O., Azevedo A. et al. Early prediction of treatment failure in severe community-acquired pneumonia: The PRoFeSs score. J Crit Care. 2019; 53: 38–45. DOI: 10.1016/j.jcrc.2019.05.020
  22. Zhao L., Bao J., Shang Y. et al. The prognostic value of serum albumin levels and respiratory rate for community-acquired pneumonia: A prospective, multi-center study. PLoS One. 2021; 16 (3): e0248002. DOI: 10.1371/journal.pone.0248002